骨关节炎药物市场预计到 2031 年将达到 177 亿美元。 Osteoarthritis Drugs Market Expected to Hit USD 17.7 billion by 2031.
预计2023年至2031年，全球骨关节炎药物市场将以8.5%的复合年增长率增长，到2031年估值将达到177亿美元。 The global osteoarthritis drugs market is projected to grow at a CAGR of 8.5% from 2023 to 2031, reaching a valuation of $17.7 billion by 2031. 这一增长是由持续的医学研究和药物开发进步以及人口老龄化导致骨关节炎患病率上升推动的。 This growth is driven by ongoing medical research and pharmaceutical development advancements, coupled with the increasing aging population leading to a rise in osteoarthritis prevalence. 到 2023 年底，市场价值预计将达到 86 亿美元。 By the end of 2023, the market is expected to be valued at $8.6 billion.